Skip to main content

Advertisement

SpringerLink
Log in

Bilateral adrenalectomy for Cushing’s disease

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Purpose

Review the indications, outcomes, and consequences of bilateral adrenalectomy (BLA) in patients with Cushing’s disease.

Methods

A literature review was performed.

Results

The primary therapy for Cushing’s disease is surgery, with medical therapy and radiation therapy relegated to an adjuvant role. BLA is indicated in cases of persistent disease following pituitary surgery or in situations where rapid normalization of hypercortisolism is required. When performed via the laparoscopic approach, BLA is associated with a significantly reduced morbidity compared to the traditional, open approach. Following BLA, patients are at risk for adrenal crisis and the concern of Nelson’s syndrome. However, BLA leads to a rapid resolution of the signs and symptoms of CS and leads to an improved long-term quality of life.

Conclusion

BLA should be considered in the treatment algorithm for patients with persistent CD after failed pituitary surgery, especially in patients who have severe consequences of hypercortisolism or desire pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grua JR, Nelson DH (1991) ACTH-producing pituitary tumors. Endocrinol Metab Clin N Am 20:319–362

    CAS  Google Scholar 

  2. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454–2462

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Gil-Cardenas A, Herrera MF, Diaz-Polanco A, Rios JM, Pantoja JP (2007) Nelson’s syndrome after bilateral adrenalectomy for Cushing’s disease. Surgery 141:147–151; discussion 151–142

    Article  PubMed  Google Scholar 

  4. Fleseriu M, Petersenn S (2012) Medical management of Cushing’s disease: What is the future? Pituitary 15:330–341

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Godbout A, Manavela M, Danilowicz K, Beauregard H, Bruno OD, Lacroix A (2010) Cabergoline monotherapy in the long-term treatment of Cushing’s disease. Eur J Endocrinol 163:709–716

    Article  CAS  PubMed  Google Scholar 

  6. Castinetti F, Guignat L, Giraud P, Muller M, Kamenicky P, Drui D, Caron P, Luca F, Donadille B, Vantyghem MC, Bihan H, Delemer B, Raverot G, Motte E, Philippon M, Morange I, Conte-Devolx B, Quinquis L, Martinie M, Vezzosi D, Le Bras M, Baudry C, Christin-Maitre S, Goichot B, Chanson P, Young J, Chabre O, Tabarin A, Bertherat J, Brue T (2014) Ketoconazole in Cushing’s disease: Is it worth a try? J Clin Endocrinol Metab 99:1623–1630

    Article  CAS  PubMed  Google Scholar 

  7. Lan BY, Taskin HE, Aksoy E, Birsen O, Dural C, Mitchell J, Siperstein A, Berber E (2014) Factors affecting the surgical approach and timing of bilateral adrenalectomy. Surg Endosc. doi:10.1007/s00464-014-3891-1

  8. Gumbs AA, Gagner M (2006) Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab 20:483–499

    Article  PubMed  Google Scholar 

  9. Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after laparoscopic bilateral adrenalectomy for Cushing’s disease. Surgery 132:1064–1068; discussion 1068–1069

    Article  PubMed  Google Scholar 

  10. Takata MC, Kebebew E, Clark OH, Duh QY (2008) Laparoscopic bilateral adrenalectomy: results for 30 consecutive cases. Surg Endosc 22:202–207

    Article  CAS  PubMed  Google Scholar 

  11. Ritzel K, Beuschlein F, Mickisch A, Osswald A, Schneider HJ, Schopohl J, Reincke M (2013) Clinical review: outcome of bilateral adrenalectomy in Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab 98:3939–3948

    Article  CAS  PubMed  Google Scholar 

  12. Smith PW, Turza KC, Carter CO, Vance ML, Laws ER, Hanks JB (2009) Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy. J Am Coll Surg 208:1059–1064

    Article  PubMed  Google Scholar 

  13. Vella A, Thompson GB, Grant CS, van Heerden JA, Farley DR, Young WF Jr (2001) Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 86:1596–1599

    CAS  PubMed  Google Scholar 

  14. Chalmers RA, Mashiter K, Joplin GF (1981) Residual adrenocortical function after bilateral “total” adrenalectomy for Cushing’s disease. Lancet 2:1196–1199

    Article  CAS  PubMed  Google Scholar 

  15. Osswald A, Plomer E, Dimopoulou C, Milian M, Blaser R, Ritzel K, Mickisch A, Knerr F, Stanojevic M, Hallfeldt K, Schopohl J, Kuhn KA, Stalla G, Beuschlein F, Reincke M (2014) Favorable long-term outcomes of bilateral adrenalectomy in Cushing’s disease. Eur J Endocrinol 171:209–215

    Article  CAS  PubMed  Google Scholar 

  16. Morris LF, Harris RS, Milton DR, Waguespack SG, Habra MA, Jimenez C, Vassilopoulou-Sellin R, Lee JE, Perrier ND, Grubbs EG (2013) Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndrome. Surgery 154:1174–1183; discussion 1183–1174

    Article  PubMed Central  PubMed  Google Scholar 

  17. Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing’s disease: a 10-year experience. Ann Surg 245:790–794

    Article  PubMed Central  PubMed  Google Scholar 

  18. Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, Ventz M, Quinkler M, Allolio B (2010) Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 162:597–602

    Article  CAS  PubMed  Google Scholar 

  19. Assie G, Bahurel H, Coste J, Silvera S, Kujas M, Dugue MA, Karray F, Dousset B, Bertherat J, Legmann P, Bertagna X (2007) Corticotroph tumor progression after adrenalectomy in Cushing’s disease: a reappraisal of Nelson’s syndrome. J Clin Endocrinol Metab 92:172–179

    Article  CAS  PubMed  Google Scholar 

  20. Barber TM, Adams E, Ansorge O, Byrne JV, Karavitaki N, Wass JA (2010) Nelson’s syndrome. Eur J Endocrinol 163:495–507

    Article  CAS  PubMed  Google Scholar 

  21. Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study group of the Italian society of endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 84:440–448

    CAS  PubMed  Google Scholar 

  22. Vik-Mo EO, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rodahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2009) Gamma knife stereotactic radiosurgery of Nelson syndrome. Eur J Endocrinol 160:143–148

    Article  CAS  PubMed  Google Scholar 

  23. Jornayvaz FR, Assie G, Bienvenu-Perrard M, Coste J, Guignat L, Bertherat J, Silvera S, Bertagna X, Legmann P (2011) Pregnancy does not accelerate corticotroph tumor progression in Nelson’s syndrome. J Clin Endocrinol Metab 96:E658–E662

    Article  CAS  PubMed  Google Scholar 

  24. Jenkins PJ, Trainer PJ, Plowman PN, Shand WS, Grossman AB, Wass JA, Besser GM (1995) The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 80:165–171

    CAS  PubMed  Google Scholar 

  25. Casulari LA, Naves LA, Mello PA, Pereira Neto A, Papadia C (2004) Nelson’s syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment. Horm Res 62:300–305

    Article  CAS  PubMed  Google Scholar 

  26. Aronin N, Krieger DT (1980) Sustained remission of Nelson’s syndrome after stopping cyproheptadine treatment. N Engl J Med 302:453–455

    Article  CAS  PubMed  Google Scholar 

  27. Lamberts SW, Uitterlinden P, Klijn JM (1989) The effect of the long-acting somatostatin analogue SMS 201–995 on ACTH secretion in Nelson’s syndrome and Cushing’s disease. Acta Endocrinol (Copenh) 120:760–766

    CAS  Google Scholar 

  28. Katznelson L (2013) Sustained improvements in plasma ACTH and clinical status in a patient with Nelson’s syndrome treated with pasireotide LAR, a multireceptor somatostatin analog. J Clin Endocrinol Metab 98:1803–1807

    Article  CAS  PubMed  Google Scholar 

  29. Raverot G, Sturm N, de Fraipont F, Muller M, Salenave S, Caron P, Chabre O, Chanson P, Cortet-Rudelli C, Assaker R, Dufour H, Gaillard S, Francois P, Jouanneau E, Passagia JG, Bernier M, Cornelius A, Figarella-Branger D, Trouillas J, Borson-Chazot F, Brue T (2010) Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J Clin Endocrinol Metab 95:4592–4599

    Article  CAS  PubMed  Google Scholar 

  30. Mehta GU, Sheehan JP, Vance ML (2013) Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing’s disease on the incidence of Nelson’s syndrome. J Neurosurg 119:1493–1497

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

This research was supported by Novartis Pharmaceuticals.

Author information

Authors and Affiliations

  1. Departments of Medicine and Neurosurgery, Stanford University School of Medicine, 875 Blake Wilbur Dr MC 5826, Stanford, CA, 94305, USA

    Laurence Katznelson

Authors
  1. Laurence Katznelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurence Katznelson.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katznelson, L. Bilateral adrenalectomy for Cushing’s disease. Pituitary 18, 269–273 (2015). https://doi.org/10.1007/s11102-014-0633-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-014-0633-2

Keywords

Search

Navigation